Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Tempest Therapeutics, Inc.Tempest Therapeutics Reports $10.9 Million Net Loss in Q1 2025, Announces Workforce Reduction
Elicio Therapeutics, Inc.Elicio Therapeutics Reports $11.2 Million Net Loss in Q1 2025, Seeks Additional Financing
Pelthos Therapeutics Inc.Channel Therapeutics Reports Q1 2025 Financial Results, Faces Ongoing Challenges Amid Merger Agreement
WILLAMETTE VALLEY VINEYARDS INCWillamette Valley Vineyards Reports Increased Net Loss and Revenue Decline in Q1 2025
SurgePays, Inc.SurgePays Reports 66.3% Revenue Decline and $7.6 Million Operating Loss in Latest Quarter
Cohen Circle Acquisition Corp. ICohen Circle Acquisition Corp. I Reports Q1 2025 Financial Results with Net Income Turnaround
SURF AIR MOBILITY INC.Surf Air Mobility Reports 23% Revenue Decline and Improved Operating Loss in Q1 2025
Regen BioPharma IncRegen BioPharma Reports Stable Revenue but Significant Losses for Fiscal Year 2024
TANCHENG GROUP CO., LTD.Tancheng Group Reports 8.2% Revenue Decline and Increased Net Loss in Q1 2025
Transportation & Logistics Systems, Inc.Transportation and Logistics Systems Reports $498K Net Loss Amid Operational Cessation
Energous CorpEnergous Corporation Reports 436% Revenue Increase and Reduced Net Losses in Q1 2025
Nutex Health, Inc.Nutex Health Inc. Reports 213.5% Revenue Growth to $211.8 Million in Latest Quarter
Rezolute, Inc.Rezolute Reports $18.9 Million Net Loss and Increased R&D Expenses for Fiscal Quarter Ending March 31, 2025
ACTELIS NETWORKS INCActelis Networks Reports $721.7 Million Revenue in Q1 2025, Improves Net Loss
Camp4 Therapeutics CorpCAMP4 Therapeutics Reports Q1 2025 Financial Results with Modest Revenue Growth
CHAIN BRIDGE BANCORP INCChain Bridge Bancorp Reports Increased Net Income and Asset Growth in Q1 2025
ALICO, INC.Alico, Inc. Reports Significant Financial Decline and Strategic Shift in Q2 FY 2025
Erasca, Inc.Erasca Reports $30.97 Million Net Loss in Q1 2025, Decreased from Previous Year
Hyperfine, Inc.Hyperfine Reports $2.1 Million Revenue Decline and $9.4 Million Net Loss in Q1 2025
Ensysce Biosciences, Inc.Ensysce Biosciences Reports Q1 2025 Financial Results with Improved Net Loss and Increased Revenue
Eton Pharmaceuticals, Inc.Eton Pharmaceuticals Reports 116% Revenue Growth to $17.3 Million in Latest Quarter
BLOOMIA HOLDINGS, INC.Lendway Reports 55% Revenue Growth and Net Income Turnaround in Latest Quarter
Evoke Pharma IncEvoke Pharma Reports 77% Increase in Net Product Sales, Faces Ongoing Financial Challenges
EXELIXIS, INC.Exelixis Reports 31% Revenue Growth to $555.4 Million in Q1 2025
Lineage Cell Therapeutics, Inc.Lineage Cell Therapeutics Reports $1.5 Million Revenue in Q1 2025, Net Loss Improves